Abstract
Our findings showed an S-shaped association between albumin changes and mortality in older patients with acute myocardial infarction (AMI), with inflection points at approximately -3.27 g/L and 0.92 g/L. Furthermore, changes in albumin levels were negatively correlated with the incidence of gastrointestinal bleeding and acute heart failure. These results provide valuable insights for clinical treatment strategies in geriatric cardiology.
Introduction
Acute myocardial infarction (AMI) remains a primary cause of mortality globally, particularly among older adults. While serum albumin is a well-established marker for nutritional status and inflammation, clinical assessments typically rely on a single "snapshot" measurement taken at admission. However, AMI is a dynamic physiological event; complications such as heart failure or renal stress can rapidly alter plasma volume and hepatic synthesis, leading to significant fluctuations in albumin levels during hospitalization. This study investigates whether the trajectory of these changes offers superior prognostic value compared to static baseline readings.
Methods and Data
The researchers conducted a retrospective observational study using clinical data from the Department of Cardiology at Shandong University Qilu Hospital, spanning September 2017 to March 2022.
Study Population
The initial pool consisted of 3,235 patients. After applying exclusion criteria—including age under 65, pre-existing complex cardiac conditions (e.g., endocarditis, valvular disease), and missing albumin data—a final cohort of 288 patients was established.
Statistical Analysis
Albumin change was defined as the difference between the average level during hospitalization and the level at admission. To analyze non-linear relationships, restricted cubic splines (RCS) were integrated into multivariable-adjusted Cox regression models. These models were adjusted for a wide range of covariates, including BMI, comorbidities (diabetes, hypertension, stroke), and pharmacological interventions (statins, antiplatelets, anticoagulants).
Results
The study revealed a significant non-linear, S-shaped relationship between albumin fluctuations and patient mortality.
The S-Curve and Inflection Points
The risk of mortality does not follow a linear path. For all-cause mortality, critical inflection points were identified at -3.27 g/L and 0.92 g/L. Between these points, the Odds Ratio (OR) for all-cause death was 2.12, indicating a peak risk zone.
Secondary Clinical Outcomes
Beyond mortality, albumin changes demonstrated a negative correlation with major complications:
- Gastrointestinal (GI) Hemorrhage: OR 0.87 (95% CI: 0.81–0.94, p < 0.001).
- Acute Heart Failure (AHF): OR 0.86 (95% CI: 0.75–0.99, p = 0.046).
In patients over 75, an increase in albumin levels was particularly protective against these complications, likely due to improved oncotic pressure and vascular stability.
Discussion and Conclusion
These findings suggest that albumin is more than a nutritional proxy; it serves as a functional indicator of vascular integrity and antioxidant capacity during the acute phase of AMI. Significant drops in albumin (exceeding 3.27 g/L) signal a failure in compensatory mechanisms, identifying high-risk patients who may benefit from targeted monitoring or albumin supplementation.
Limitations
The study's retrospective nature and high exclusion rate due to missing data (nearly 750 patients) may limit generalizability. Future prospective, multi-center trials are necessary to validate these inflection points and determine if proactive albumin management can directly improve survival rates in the older AMI population.
Summary updated